| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.02 |